{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:34:24Z","timestamp":1744058064700},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":5113,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1046\/j.0022-202x.2001.00036.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:37:46Z","timestamp":1047443866000},"page":"238-243","source":"Crossref","is-referenced-by-count":3,"title":["Prophylactic and Therapeutic Vaccines for Genital Papillomavirus Infection"],"prefix":"10.1016","volume":"6","author":[{"given":"Daniel","family":"Carrasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody","family":"Van der Straten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0010","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0002-9378(96)70110-2","article-title":"Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with synthetic human papillomavirus type 16, E7 epitopes","volume":"175","author":"Alexander","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1991.03460040048027","article-title":"Genital human papillomavirus infection in female University students as determined by a PCR-based method","volume":"265","author":"Bauer","year":"1991","journal-title":"JAMA"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000163910","article-title":"A formalin inactivated vaccine protects against mucosal papillomavirus infection: a canine model","volume":"62","author":"Bell","year":"1994","journal-title":"Pathobiology"},{"issue":"Suppl. 1","key":"10.1046\/j.0022-202x.2001.00036.x_bb0025","first-page":"S37","article-title":"Genital warts and their treatment","volume":"28","author":"Beutner","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/514964","article-title":"External genital warts: report of the American Medical Association Consensus Conference","volume":"27","author":"Beutner","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0035","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(96)90674-1","article-title":"A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer","volume":"347","author":"Borysiewiez","year":"1996","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective","volume":"7","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0045","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0264-410X(96)00117-X","article-title":"Construction and characterization of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer","volume":"14","author":"Boursnell","year":"1996","journal-title":"Vaccine"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0050","series-title":"Proceedings of the 17th International Papillomavirus Conference January 9\u201315, Charleston SC","article-title":"The HIV16 E7 peptide based vaccine trial in end stage cervical carcinoma: final report","author":"Brandt","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0055","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/JVI.69.6.3959-3963.1995","article-title":"Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection","volume":"6","author":"Breitburd","year":"1995","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0060","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/JCM.31.10.2667-2673.1993","article-title":"Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques","volume":"31","author":"Brown","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0065","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/0022-1317-73-5-1261","article-title":"Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions","volume":"73","author":"Christensen","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0070","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/JVI.70.2.960-965.1996","article-title":"Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus","volume":"70","author":"Christensen","year":"1996","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0140-6736(91)91636-9","article-title":"Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein","volume":"337","author":"Cooney","year":"1991","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0080","series-title":"Proceedings of the 17th International Papillomavirus Conference; January 9\u201315, Charleston, SC, USA","article-title":"Chimeric papillomavirus virus-like particles induce antigen-specific therapeutic immunity against tumours expressing the HPV-16 E7 protein","author":"Da Silva","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0085","first-page":"314","article-title":"Protection against papillomavirus with a polynucleotide vaccine","volume":"713","author":"Donnelly","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/mpat.1996.0113","article-title":"Cell mediated immunity induced in mice by HPV 16, L1 virus-like particles","volume":"22","author":"Dupuy","year":"1997","journal-title":"Microb Pathogen"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0095","series-title":"Proceedings of the 17th International Papillomavirus Conference January 9\u201315, Charleston, SC. USA","article-title":"Production of chimeric human papillomavirus 16, E4 \u2013 hepatitis B core recombinant particles","author":"El Mehdaoui","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0100","series-title":"The Hidden Epidemic: Confronting Sexually Transmitted Diseases, Committee on Prevention and Control of Sexually Transmitted Diseases","author":"Eng","year":"1996"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0105","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.1830230929","article-title":"Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16- transformed cells","volume":"23","author":"Feltkamp","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1099\/0022-1317-75-1-157","article-title":"Immune response to human papillomavirus type-16, E6 gene in a live vaccina","volume":"75","author":"Gao","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.2910490224","article-title":"Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts","volume":"49","author":"Ghim","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1073\/pnas.80.2.560","article-title":"Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers","volume":"80","author":"Gissmann","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0125","first-page":"1229","article-title":"Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in ProvaxTM","volume":"12","author":"Hariharan","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0130","series-title":"Proceedings of the 17th International Papillomavirus Conference January 9\u201315 Charleston, SC. USA","article-title":"An immune response to human papillomavirus type 16 early protein E2 following immunization with adjuvant MF 59 in a mouse model","author":"Heineman","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0135","series-title":"Proceedings of the 17th International Papillomavirus Conference January 9\u201315, Charleston, SC, USA","article-title":"Immune responses to the human papillomavirus type 16 early protein E2 following several methods of immunization","author":"Hibma","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00001703-199802000-00004","article-title":"Prospects for human papillomavirus vaccine development emerging HPV vaccines","volume":"10","author":"Hines","year":"1998","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0042-6822(91)90819-W","article-title":"Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins","volume":"184","author":"Jarrett","year":"1991","journal-title":"Virology"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0155","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/JVI.71.11.8467-8474.1997","article-title":"Recombinant Listeria monocytogenes vaccination eliminates papillomavirus induced tumors and prevents papilloma formation from viral DNA","volume":"71","author":"Jensen","year":"1997","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000150171","article-title":"Bovine serological response to a recombinant BPV-1 major capsid protein vaccine","volume":"31","author":"Jin","year":"1990","journal-title":"Intervirologv"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/smvy.1996.0015","article-title":"Cellular immunity against human papillomavirus associated cervical cancer","volume":"7","author":"Kast","year":"1996","journal-title":"Semin Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.67.4.551","article-title":"The course of virus-induced rabbit papillomas as determined by virus, cells, and host","volume":"67","author":"Kidd","year":"1938","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/viro.1996.0220","article-title":"Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization","volume":"219","author":"Kirnbauer","year":"1996","journal-title":"Virology"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0180","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/jnci\/85.12.934","article-title":"Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: implications for current views and treatment","volume":"85","author":"Kiviat","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","article-title":"Epidemiology of genital human papillomavirus infection","volume":"10","author":"Koutsky","year":"1988","journal-title":"Epidemiol Rev"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0190","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","article-title":"A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection","volume":"327","author":"Koutsky","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s002620050302","article-title":"Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains","volume":"43","author":"Krul","year":"1996","journal-title":"Cancer Immunol Immunother"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0200","series-title":"Medical Society for the Study of Venereal Disease Spring Meeting. Oxford, UK","article-title":"A phase IIa therapeutic vaccine for genital warts","author":"Lacey","year":"1997"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0205","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/JVI.67.7.4154-4162.1993","article-title":"Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product","volume":"67","author":"Lin","year":"1993","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0210","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0042-6822(92)90463-Y","article-title":"Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus","volume":"187","author":"Lin","year":"1992","journal-title":"Virology"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0215","first-page":"21","article-title":"Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen","volume":"56","author":"Lin","year":"1996","journal-title":"Cancer Res"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0220","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0264-410X(95)00216-N","article-title":"Immunization of mice using Salmonella typhimurium expressing human papillomavirus type-16 E7 epitopes inserted into hepatitis-B virus core antigen","volume":"14","author":"London","year":"1996","journal-title":"Vaccine"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00006250-199203000-00002","article-title":"Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types","volume":"79","author":"Lorinez","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0230","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/514105","article-title":"Human papillomavirus type 11 (HPV- 11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast","volume":"176","author":"Lowe","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0235","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1099\/0022-1317-78-4-917","article-title":"Serological and T -helper cell responses to human papillomavirus type 16, L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls","volume":"18","author":"Luxton","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0240","series-title":"Proceedings of the 17th International Papillomavirus Conference January 9\u201315, Charleston, SC, USA","article-title":"Cell-mediated immune responses to recombinant HPV-16, E6E7hh protein generated by immunization with creating lscomatrixTM adjuvant","author":"Mallarios","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0042-6822(91)90470-V","article-title":"Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7","volume":"181","author":"Meneguzzi","year":"1991","journal-title":"Virology"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0250","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1128\/IAI.65.8.3328-3336.1997","article-title":"Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium, elicit mucosal and systemic neutralizing antibodies in mice","volume":"65","author":"Nardelli-Haflinger","year":"1997","journal-title":"Infect Immun"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0255","first-page":"136","article-title":"Immunization against bovine papillomavirus infection","volume":"120","author":"Pilacinski","year":"1986","journal-title":"Ciba Foundation Symp"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0260","series-title":"38th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 24\u201327, San Diego, California","article-title":"A phase I study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers","author":"Reichman","year":"1998"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0265","series-title":"Proceedings of the 17th International Papillomavirus Conference January 9\u201315, Charleston, SC, USA","article-title":"Evaluation of the safety and immunogenicity of a recombinant HPV-11, L1 virus like particle vaccine in healthy adult volunteers","author":"Reichman","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0270","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JVI.67.4.1936-1944.1993","article-title":"Expression of human papillomavirus type 11, L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles","volume":"67","author":"Rose","year":"1993","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0275","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0733-8635(05)70056-5","article-title":"Toward a human papillomavirus vaccine","volume":"16","author":"Rowen","year":"1998","journal-title":"Dermatol Clinics"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0280","series-title":"Medical Society for the Study of Venereal Disease Spring Meeting. Oxford, UK","article-title":"A phase IIa open study to evaluate the safety, immunogenicity and clinical response to TA-GW given in combination with cryotherapy to men with genital warts","author":"Rowen","year":"1997"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0285","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","article-title":"Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia","volume":"85","author":"Schiffman","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0290","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/j.1460-2075.1988.tb03185.x","article-title":"Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma","volume":"7","author":"Schlegel","year":"1988","journal-title":"EMBO J"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1097-0339(199801)18:1<5::AID-DC2>3.0.CO;2-G","article-title":"Prospects for a prophylactic HPV vaccine: rationale and future implications for cervical cancer screening","volume":"18","author":"Sherman","year":"1998","journal-title":"Diagn Cytopathol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0300","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.65.2.219","article-title":"Immunization of rabbits to infectious papillomatosis","volume":"65","author":"Shope","year":"1935","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0305","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0042-6822(90)90092-6","article-title":"Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1","volume":"174","author":"Steele","year":"1990","journal-title":"Virology"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0310","first-page":"145","article-title":"Human papillomavirus immunology and vaccine prospects","volume":"21","author":"Steller","year":"1996","journal-title":"Monogr Natl Cancer Inst"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0315","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1073\/pnas.92.25.11553","article-title":"Systemic immunizations with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas","volume":"92","author":"Suzich","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2249.1995.tb08349.x","article-title":"A vaccine conjugate of ISCAR immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants","volume":"101","author":"Tindle","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0325","series-title":"Detection of Genital Human Papillomavirus Infections: Critical Review of Methods and Prevalence Studies in Relation to Cervical Cancer","author":"Walboomers","year":"1994"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0330","first-page":"1345","article-title":"Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction","volume":"140","author":"Zaki","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0335","series-title":"Proceedings of the 17th International Papillomavirus Conference January 9\u201315, Charleston, SC","article-title":"A phase II trial of HPV 6B virus like particles as immunotherapy for genital warts","author":"Zhang","year":"1999"},{"key":"10.1046\/j.0022-202x.2001.00036.x_bb0340","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-3083.1995.tb03696.x","article-title":"Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papillomavirus 16 in H-2 (D) mice","volume":"42","author":"Zhu","year":"1995","journal-title":"Scand J Immunol"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15529138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T21:16:49Z","timestamp":1584479809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15529138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0022202X15529138"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.00036.x","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}